Responses
Regular and Young Investigator Award Abstracts
Cellular Therapies
254 TGF-beta blockade combined with activation-induced IL12 secretion synergize to optimize potency of MUC1-CAR T-cells in preclinical targeting of triple-negative breast cancer
Compose a Response to This Article
Other responses
No responses have been published for this article.
